Review Registration - Organization

This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.

Registration ID: 46592581
Registration number: 7619-2818
Submitted by lobbyist on: April 17, 2019 12:31:34 PM
Accepted by Registrar on: May 14, 2019 11:02:13 AM

Designated Filer Information

Yuceland, Gamze  
2201 Bristol Suite 700  
Oakville, ON, L6H 0J8
905-469-9333
Canada  

Organization Information

Takeda Canada Inc.  
Takeda is a global pharmaceutical leader founded by Chobei Takeda in 1781 in Osaka, Japan. For over 237 years, we've aimed to make an impact on patients' lives by translating science into life-changing medicines. Our commitment to bringing better health and brighter futures to people around the world is built on a sustainable portfolio of innovative medicines
2201 Bristol Suite 700  
Oakville, ON, L6H 0J8
905-469-9333
Canada  

Relevant Affiliates

The client has no relevant affiliates.

Government or Government Agency Funding


The organization does not receive any funding from a government or government agency.

Other Controlling or Directing Interests

Business Name Mailing Address Contact Information
Takeda Pharmaceutical Company Limited Takeda Global Headquarters 1-1 Nihonbashi-Honcho 2-Chrome, Chuo-Ku
Tokyo,

Japan
Phone:

Active Registration Period

April 17, 2019  
October 17, 2019  

Organization's In-House Lobbyists

 



Name: Berberich, Norm
 
April 17, 2019  
Inactivation Date: November 17, 2019

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Economic Development and Trade

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019

Education

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019

Name: Nguyen, Tricia
 
April 17, 2019  
Inactivation Date: November 17, 2019

BC Public Office Background

This individual has not held any public office positions in BC.

Lobbying Activities

Economic Development and Trade

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019

Education

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019

Health

Awarding, amendment or termination of a contract, grant or financial benefit

Product education on Takeda oncology and IBD products, including Entyvio, Ninlaro and Alunbrig, related to unique MoA and delivery, clinical and economic value, and how these products address unmet patient needs and contribute to the health of Albertans. Partnering with BioAlberta, Economic and Trade Development, in support of projects related to real-world evidence generation to address gaps in data in one or more of the following therapeutic areas: neurosciences, gastroenterology, oncology as well as rare diseases for therapeutic areas.

Target Contacts

Target Type Name Title or Constituency Date Added
Minister Chow, George Minister of State for Trade April 17, 2019
Minister Dix, Adrian Minister of Health April 17, 2019
Minister Fleming, Rob Minister of Education April 17, 2019